ANI Pharmaceuticals Announces Launch of Authorized Generic of Lithobid® Extended Release Tablets
ANI Pharmaceuticals, Inc. | December 21, 2016
ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced the launch of Lithium Carbonate Extended Release Tablets, 300mg, an authorized generic of Lithobid®, which is used in the treatment of manic episodes of Bipolar Disorder. The annual US market for lithium carbonate is approximately $19 million, per IMS Health…